The rates of mortality, morbidity as hospitalizations, and congenital anomalies in the Windsor Area of Concern ranked among the highest of the 17 Areas of Concern on the Canadian side of the Great Lakes for selected end points that might be related to pollution in this relatively highly industrialized city. Mortality and morbidity rates from all causes were higher than in the rest of the province. Anomalously high rates of diseases included various cancers; endocrine, nutritional, metabolic, and immunity disorders; diseases of the blood and blood-forming organs, nervous system and sense organs, circulatory and respiratory systems, digestive system, genitourinary system, skin and subcutaneous tissue, musculoskeletal system and connective tissues; congenital anomalies, and infant mortality. Of particular concern was the early onset of the elevated rates of many of these diseases and conditions. Comparison of these incident rates with those in Hamilton, another industrial municipality in southern Ontario, suggested that in addition to a variety of local sources of industrial pollution from automobile manufacturing and use, transboundary air and water pollution from Detroit, Michigan, should be investigated as potentially important causes of these health outcomes in the Windsor Area of Concern. Some of the institutional and political trends of the past decade may need to be reversed before effective remedial programs are implemented for cleaning up contaminated sediments and for containment of leaking hazardous waste sites. This pilot project would seem to be a useful preliminary method of integrating human health concerns and of priority setting for the administration of the Great Lakes Water Quality Agreement and the Canada-United States Air Quality Agreement.
Notes
Cites: Folia Med Cracov. 1993;34(1-4):29-478175062
Cites: Ann N Y Acad Sci. 1992 May 11;648:154-601322079
Cites: Occup Med. 1994 Jul-Sep;9(3):471-947831593
Cites: Sci Total Environ. 1995 Jan 15;160-161:571-57892586
Cites: Am J Epidemiol. 1995 May 1;141(9):850-627717362
Cites: Crit Rev Toxicol. 1995;25(1):1-247734058
Cites: Occup Environ Med. 1995 Nov;52(11):773-48535499
Cites: Am J Public Health. 1996 May;86(5):674-78629718
Cites: Am J Public Health. 1996 May;86(5):678-838629719
Cites: Environ Health Perspect. 1995 Dec;103 Suppl 9:3-58635437
Cites: Environ Health Perspect. 1995 Nov;103 Suppl 8:153-608741776
Cites: N Engl J Med. 1996 Sep 12;335(11):783-98703183
Cites: Toxicol Ind Health. 1996 May-Aug;12(3-4):315-258843549
Cites: Rheum Dis Clin North Am. 1996 Nov;22(4):737-498923593
Cites: Environ Res. 1997 Jan;72(1):24-319012369
Cites: Epidemiology. 2000 Jan;11(1):44-810615842
Cites: Environ Health Perspect. 2000 May;108(5):441-510811571
Cites: Toxicol Sci. 2000 Aug;56(2):431-610911003
Cites: Environ Health Perspect. 2000 Dec;108(12):1203-711133402
Cites: Environ Health Perspect. 2001 Jan;109(1):1-511171517
Cites: Environ Health Perspect. 2001 Mar;109(3):245-5111333185